Here are five key points:
1. Worldwide sales for the company were $173.4 million, a 13.8 percent increase year-over-year.
2. Globus Medical’s net income for the second quarter was $45 million, a 56.9 percent increase.
3. The company’s second quarter sales in the U.S., including robotics, increased 15.1 percent year-over-year. International sales increased by 7.2 percent.
4. Diluted earnings per share for the second quarter was $0.44, a 38 percent increase year-over-year. The company attributed the spike to its ExcelsiusGPS robotic and navigation system.
5. Globus Medical anticipates its full-year sales to be around $700 million. Previous guidance put the company’s full-year 2018 sales at $695 million.
To view the full financial report, click here.
More articles on devices and implants:
NuVasive reports $282M in Q2 revenue — Up 8.5%
Stryker, Zimmer Biomet, Smith & Nephew & more: 9 device company notes
What to expect from NuVasive for 2nd half of 2018 and beyond: 7 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
